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leak; (2) the differences in LOS, readmission, post-operative infection, and total
inpatient costs between the patients with anastomotic leaks and those without
leaks. Chi square test and T test were used to compare outcomes between two
cohorts, before and after employing propensity-score matching technique based
on a series of baseline covariates. Generalized linear model was also conducted.
RESULTS: A total of 6174 (6.18%) patients with colorectal surgeries had 30-day
anastomotic leak during 2008-2010.The patients with anastomotic leak had 1.3
times higher 30-day readmission (p0.01), and 1.9 times higher postoperative in-
fection (p0.01) compared to the patient without anastomotic leak. Anastomotic
leak incurred additional LOS of 7.3 days and additional average hospital cost of
$24,399 for index hospitalization alone. When the extra burden of readmission was
added, the average incremental LOS increased to 9.5 days, and the average incre-
mental hospital costs increased to $28,597. CONCLUSIONS: Anastomotic leaks in
colorectal surgeries increase clinical and economic burden by 0.5 to 1.8 times in
terms of additional readmission, postoperative infection, LOS, and hospital costs.
The results underscore the potential advantage of cost reduction by preventing the
anastomotic leaks after colorectal surgeries.
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OBJECTIVES: To encourage quality improvements and assess high expenditures
for patients with coronary artery bypass graft (CABG) surgery and hospital quality
in Turkey. METHODS: Using the Turkish National Health Insurance Database
(2009-2011), CABG surgery patients were identified using the appropriate Interna-
tional Classification of Diseases Tenth Revision Clinical Modification codes. High-
cost cardiac surgery patients had annual health care costs in the top 20% post-
surgery. The empirical Bayes approach was used to combine mortality rates with
hospital volume for quality index, weighing observed mortality according to esti-
mation reliability, with the remaining weight placed on hospital volume. The rela-
tionship between hospital quality and high-cost payments was assessed using
chi-square tests. RESULTS: Total annual health care payments for 20,126 identified
CABG patients were approximately a70 million. High-cost patients incurred 31% of
the total expenditures. Although disease severity did not differ for patients across
hospitals, those in the lowest quintile cared for 25% of high-costs surgery patients,
compared with only 18% in the highest quality hospitals (p0.0001). a4M in asso-
ciated cost savings was calculated for patients shifting from low- to high-quality
hospitals. CONCLUSIONS: Results imply that hospital quality improvements can
reduce costs and improve morbidity and mortality rates in Turkey.
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OBJECTIVES: Estimate the cost of a adhesiolysis (surgical procedure to remove
adhesions abdomen or pelvis) in the Brazilian private health care system.
METHODS: Using a claims database, 1585 patients were classified according to
code Brazilian Private HealthCare System (TUSS code) and observed between Jan-
uary/2009 to December/2011 all costs associated with the surgical procedure to
remove adhesions abdomen or pelvis were considered across seven major catego-
ries: materials, medications, procedure, exams, alimentation, rates and medicinal
gases. RESULTS: Out of the 1585 patients that used the private health care system
and made a adhesiolysis in a period of 36 months, 93% are women and the majority
between 30 -34 years old (27,22%) with an expenditure of about R$ 13millhon with
average cost , per patient of R$ 8.228,39 were hospitalized for 4 days. The 56% of
patients remove the adhesion after a surgical abdominal or pelvic and them ex-
penditure 51% was due to procedure and materials, followed by rates (21%), med-
ication (20%), alimentation (3%), exams (3%) and medicinal gases (2%).
CONCLUSIONS: . Procedure spending of adhesiolysis could have been avoided if
there was the use of barreir.
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OBJECTIVES: A recent pilot study suggests the current NHS HRG Tariff for parathy-
roidectomy (PTX) (£2,710 and £2,209 in patients with and without complications
respectively) is not representative of the true costs of surgery in patients with
secondary hyperparathyroidism (SHPT). This study aims to describe the health
care resources used to manage patients undergoing PTX, for SHPT, and estimate
the cost in a UK tertiary care centre. METHODS: Resource use was identified by
combining data from the PROTON renal database, and routine hospital data, for all
adults undergoing PTX for SHPT at Cardiff and Vale University Health Board from
2000-2008. Data were supplemented by a questionnaire completed by clinicians in
the Cardiff centre. Costs were obtained from the NHS reference costs, British Na-
tional Formulary and published literature. These costs were applied for the follow-
ing periods: pre-surgical, surgical, peri-surgical, and post-surgical to calculate the
total cost of PTX. RESULTS: The analysis included 124 patients (mean age 51.0, SD
13.8). Patients’ underlying renal disease had a wide range of causes, undergoing
renal replacement therapy for a mean of 7.3 years, SD 7.0 prior to PTX. The main
costs identified included the surgical stay (average £4,100, SD £2,338; mean stay 5.6
days, SD 7.4), yearly post-discharge outpatient surveillance (£735, £147 and £147, in
the first, second and third years respectively) and medications (£733, £650 and £643,
in the first, second and third years respectively). Average total cost for the pre-
surgical, surgical, and peri-surgical periods amounted to £4,968 (SD £2,361).
CONCLUSIONS: This analysis demonstrates that the cost of PTX surgery in SHPT
exceeds the current NHS HRG tariffs for PTX.
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OBJECTIVES: Cardiac surgery can result in renal impairment necessitating hemo-
filtration (HF; dialysis) which prolongs the length of therapy (LOT), days in the
intensive care unit (ICU) and is associated with an overall higher mortality. The
decision to initiate HF-therapy is currently made on increased plasma creatinine
levels, a relatively late marker (peaking days after a potentially reversible renal
dysfunction). The novel urine marker NGAL (neutrophil-gelatinase-associated li-
pocalin) measures the acute structural damage and identifies the need for HF
within hours with high accuracy. METHODS: Based on data collected in 2005-2009,
we prospectively included NGAL in an algorithm to modify the management of
HF-therapy in 2010. Changes in incidence of HF and LOT, all costs associated with
routine NGAL-testing and ICU stay (direct and indirect) as well as the economic
impact were analysed. RESULTS: A total of 528 patients were operated with no
statistical difference in numbers, case mix, risk scores and outcomes to the previ-
ous years. The expected number of patients with HF was 45.3 with an average LOT
of 7.7 days (2005-2009). Introduction of NGAL-testing added costs of € 60.00/patient
(€ 31.680/year). Although € 2047,50/day could be realized through public health
refunding, the fixed associated costs were € 3249,70/patient/day [€ 892,52 for all
supplies to operate the HF (Prismaflex, Gambro, Germany) and € 2357,18 for insti-
tutional ICU expenditure (incorporating personnel costs)] resulting in a deficit of €
1202,19/day with, and € 751,58 without HF operating. Using the new marker, only 32
patients required treatment with HF for a mean of 5.5 days and earlier initiation (1.1
days) in 2010 (p0,001). A total of 41.6 days of treatment in ICU (occupancy) were
avoided with savings of € 44.153,16. CONCLUSIONS: Routine NGAL testing and
consecutive changes in management reduced the number of HF-therapies, lengths
of therapy and ICU stay in our institution and proved to be cost-saving.
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OBJECTIVES: Minimally invasive surgery techniques (MIS) for lumbar spine fusion
allow surgical treatment of back and leg pain while aiming at minimizing tissue
injury and accelerating patient recovery. The objective of this study was to esti-
mate the cost-effectiveness of MIS compared to open surgery (OS) for the treatment
of degenerative lumbar spinal conditions in a UK setting. METHODS: Resources,
costs and differences in Health Related Quality of Life (HRQoL) after MIS and OS
were based on a literature review or derived from other public sources. Resources
included were: staff and operating room, surgical equipment, consumables, blood
loss, surgical drainage, duration of hospitalization and post-operative complica-
tions. In the base case it was assumed that the surgeons hadn’t reached the top of
the learning curve. The cost-effectiveness was expressed as the incremental cost
per QALY gained using a time horizon of two years after surgery. The costs included
the total direct medical cost associated with either procedure and the utility gain
was estimated from the Swedish national spinal registry data. RESULTS: Modeling
showed that MIS was the dominant strategy vs. open surgery yielding both cost
savings and improved HRQoL. Cost savings were driven mainly by shorter length of
hospital stay, less blood loss and fewer complications. The total cost-saving was
£639 per procedure with a small improvement in HRQoL (0.04 QALY gain after 2
years). CONCLUSIONS: MIS may be a dominant treatment option compared to OS
for spinal lumbar fusion in a UK setting. Lower costs and increased HRQoL in the
MIS group compensate for potential higher upfront costs of MIS implants and
equipment. Future analyses should consider the inclusion of indirect costs as the
majority of the patient population is below age 65 and will potentially return to
work.
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OBJECTIVES: As part of the information needed for recommendations making, we
aimed to compare the cost of systematic axillary lymph node dissection and sen-
tinel lymph node biopsy –with axillary dissection only if the sentinel node contains
metastases-, with or without intra-operative histological examination. METHODS:
Unit costs collected in a French national study were included in a model simulating
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